US stocks started the holiday-shortened week on a mixed note, with traders monitoring news of a new variant of coronavirus detected in the UK. Meanwhile, investors also welcomed news of lawmakers agreeing to a $900 billion covid-19 aid package. Markets became cautious, however, after President Donald Trump raised concerns about the package, calling it “a disgrace” and
Wall Street climbed to record highs last week despite starting the week on a negative note. Hopes of US lawmakers passing the covid-19 relief bill and another pharma giant receiving FDA clearance for its vaccine candidate spurred optimism among investors. Capitol Hill leaders said they were close to reaching a deal to provide an additional
US markets started the week on a lower note with investors still waiting for US lawmakers to announce the new stimulus package. The week ended without any agreement reached around the covid-19 relief package, while the government is eager to pass a bill before yearend. Meanwhile, Britain began its covid-19 mass vaccination program last week,
Last week started on a downbeat note for Wall Street, after stocks finished November with historic gains, with the Dow recording its strongest monthly surge since 1987. The week progressed with positive news related to the coronavirus vaccine being approved by the UK, following the completion of late-stage trials. Pfizer and its German partner BioNTech
